MNMakoto Naito

Makoto Naito

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Makoto Naito has a total of 36 co-authors. Here are the top co-authors by number of shared publications:

  • Riuko Ohashi

    Histopathology Core Facility, Faculty of Medicine, Niigata University, Niigata 951-8510, Japan

    3 shared publications
  • Go Hasegawa

    Division of Cellular and Molecular Pathology, Niigata University Graduate School of Medical and Dental Sciences, Niigata University Hospital, Niigata

    2 shared publications
  • Hiroko Iwanari

    Laboratory for Systems Biology and Medicine, Research Center for Advanced Science and Technology, University of Tokyo, Tokyo, Japan

    2 shared publications
  • Shuying Jiang

    Division of Cellular and Molecular Pathology, Niigata University Graduate School of Medical and Dental Sciences, Niigata University Hospital, Niigata

    2 shared publications
  • Takao Hamakubo

    Laboratory for Systems Biology and Medicine, Research Center for Advanced Science and Technology, Tokyo University, Tokyo

    2 shared publications
  • Tatsuhiko Kodama

    Laboratory for Systems Biology and Medicine, Research Center for Advanced Science and Technology, Tokyo University, Tokyo

    2 shared publications

Latest Publications

  • The predominant expression of hepatocyte nuclear factor 4α (HNF4α) in thyroid transcription factor‐1 (TTF‐1)‐negative pulmonary adenocarcinoma

    by Ryosuke Kunii, Shuying Jiang, Go Hasegawa, Takashi Yamamoto, Hajime Umezu, Takehiro Watanabe, Masanori Tsuchida, Takehisa Hashimoto, Takao Hamakubo, Tatsuhiko Kodama, et al.

    Kunii R, Jiang S, Hasegawa G, Yamamoto T, Umezu H, Watanabe T, Tsuchida M, Hashimoto T, Hamakubo T, Kodama T, Sasai K & Naito M (2011) Histopathology58, 467–476 The predominant expression of hepatocyte nuclear factor 4α (HNF4α) in thyroid transcription factor‐1 (TTF‐1)‐negative pulmonary adenocarcinomaAims:  To investigate TTF‐1‐negative pulmonary adenocarcinoma, focusing upon mucin production and the expression of hepatocyte nuclear factor‐4α (HNF4α).Materials and methods:  Two hundred and sixty‐two cases of pulmonary adenocarcinoma were examined histologically and immunohistochemically; TTF‐1 was expressed in 222 cases (84.7%), and 40 cases (15.3%) were negative. Among TTF‐1‐negative cases there were 31 mucinous‐type tumours, and HNF4α, MUC5AC and MUC2 were expressed in 34 cases (85%), 29 cases (72.5%) and four cases (10%), respectively. In contrast, their expression was rare in TTF‐1‐positive tumours. A statistically inverse correlation was confirmed between the expression of TTF‐1 and that of HNF4α and MUC5AC.Conclusion:  Most TTF‐1‐negative pulmonary adenocarcinomas are mucinous lesions with the predominant expressionof HNF4α and MUC5AC.


  • Expression of liver X receptor α and lipid metabolism in granulocyte–macrophage colony‐stimulating factor‐induced human monocyte‐derived macrophage

    by Toshihiro Kazawa, Takashi Kawasaki, Azusa Sakamoto, Masaru Imamura, Riuko Ohashi, Shuying Jiang, Toshiya Tanaka, Hiroko Iwanari, Takao Hamakubo, Juro Sakai, et al.

    Liver X receptor (LXR) is a nuclear receptor that acts as a sterol sensor and metabolic regulator of cholesterol and lipid homeostasis. The foam cell transformation of macrophages (Mϕ) is considered a critical process in atherosclerotic lesions. The relationship, however, of the foam cell transformation of Mϕ and LXR is not fully understood. The purpose of the present study was to examine the expression of LXRα, retinoid X receptor (RXR)α, ATP‐binding cassette transporter (ABCA1), and macrophage scavenger receptor A (MSR‐A), and lipid accumulation in human monocyte‐derived Mϕ. The expression of LXRα, ABCA1, MSR‐A in 7 day cultured granulocyte–macrophage colony‐stimulating factor (GM‐CSF)‐induced Mϕ (GM‐Mϕ) was significantly higher than that in 7 day cultured M‐CSF‐induced Mϕ (M‐Mϕ). The expression levels of LXRα, ABCA1 and MSR‐A protein decreased from 48 h to 5 days after the addition of lipopolysaccharide (LPS) in GM‐Mϕ, but only MSR‐A protein decreased at 5 days after the addition of LPS in M‐Mϕ. Intracellular lipid accumulation was clearly observed when GM‐Mϕ was pre‐stimulated with LPS for 48 h and incubated with oxidized LDL for an additional 5 days. These findings suggest that the inhibitory activity of LXRα, ABCA1 and MSR‐A by LPS may be related to the transformation of Mϕs, especially GM‐Mϕ into foam cells.


  • Open Access

    Protein expression of nuclear receptors in human and murine tissues

    by So Takegoshi, Shuying Jiang, Riuko Ohashi, Alexander S. Savchenko, Hiroko Iwanari, Toshiya Tanaka, Go Hasegawa, Takao Hamakubo, Tatsuhiko Kodama, Makoto Naito

    Nuclear receptors (NR) are transcriptional regulators expressed in a variety of tissues and they play important roles in embryonic development, organogenesis and metabolic homeostasis. In order to investigate the tissue‐specific expression pattern of NR, mouse anti‐human monoclonal antibodies newly generated against various NR. Specificities of the antibodies were confirmed on immunoblotting using overexpressed proteins. Most of the antibodies recognized intrinsic protein. Among 60 monoclonal antibodies generated, 32 were applicable for immunohistochemistry. The expression pattern of NR in human liver and pancreas was confirmed on immunohistochemical staining using these antibodies. The P2 promoter‐driven hepatocyte nuclear factor 4α (HNF4α) isoform and progesterone receptor were expressed in pancreatic α‐cells, but not β‐cells in the human pancreas, suggesting an unknown role of these NR in diabetes mellitus. These antibodies were also useful for immunohistochemistry of the murine liver and pancreas. Immunoblotting using these antibodies produced similar corresponding bands both in human and mouse tissues. These monoclonal antibodies may serve as powerful tools to detect tissue‐specific localization of NR and provide a platform for future studies of NR in human and murine tissues.


  • Expression of pentraxin 3 (PTX3) in human atherosclerotic lesions

    by As Savchenko, M Imamura, R Ohashi, S Jiang, T Kawasaki, G Hasegawa, I Emura, H Iwanari, M Sagara, T Tanaka, et al.

    Pentraxin 3 (PTX3) and C‐reactive protein (CRP) are members of the pentraxin superfamily. PTX3 expression is induced in response to inflammatory signals, and is produced at sites of inflammation by several types of cell, primarily monocytes/macrophages, dendritic cells (DCs), endothelial cells, smooth muscle cells (SMCs), and fibroblasts, but is not produced by hepatocytes, which are a major source of CRP. The aim of our study was to investigate the expression pattern of PTX3 in human atherosclerotic lesions using a novel monoclonal antibody against PTX3. We examined coronary arterial thrombi containing an atherosclerotic plaque component removed from patients with acute myocardial infarction and human aortic tissues with various degrees of atherosclerosis sampled from autopsy cases. Immunohistochemical study of paraffin and frozen sections indicated that macrophages, mainly foam cells, expressed PTX3 in advanced atherosclerotic lesions. Interestingly, we also clearly observed PTX3‐positive neutrophils infiltrating into atherosclerotic plaques, suggesting that PTX3 derived from neutrophils as well as macrophages plays an important role in atherogenesis. Copyright © 2008 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.